Stabilising normal and mis-sense variant α-glucosidase

被引:12
作者
Kakavanos, Revecca
Hopwood, John J.
Lang, Debbie
Meikle, Peter J.
Brooks, Doug A. [1 ]
机构
[1] Children Youth & Womens Hlth Serv, Dept Med Genet, Lysosomal Dis Res Unit, Adelaide, SA 5006, Australia
[2] Univ Adelaide, Dept Paediat, Adelaide, SA, Australia
来源
FEBS LETTERS | 2006年 / 580卷 / 18期
关键词
alpha-glucosidase; enzyme stability; Pompe disease; enzyme enhancement;
D O I
10.1016/j.febslet.2006.06.096
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
alpha-Glucosidase (EC 3.2.1.3) is a lysosomal enzyme that hydrolyses alpha-1,4- and alpha-1,6-linkages of glycogen to produce free glucose. A deficiency in alpha-glucosidase activity results in glycogen storage disorder type II (GSD II), also called Pompe disease. Here, D-glucose was shown to be a competitive inhibitor of alpha-glucosidase and when added to culture medium at 6.0 g/L increased the production of this protein by CHO-K1 expression cells and stabilised the enzyme activity. D-Glucose also prevented a-glucosidase aggregation/precipitation and increased protein yield in a modified purification scheme. In fibroblast cells, from adult-onset GSD II patients, D-glucose increased the residual level of a-glucosidase activity, suggesting that a structural analogue Of D-glucose may be used for enzyme enhancement therapy. (c) 2006 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:4365 / 4370
页数:6
相关论文
共 29 条
[1]   OVEREXPRESSION OF N-ACETYLGALACTOSAMINE-4-SULFATASE INDUCES A MULTIPLE SULFATASE DEFICIENCY IN MUCOPOLYSACCHARIDOSIS-TYPE-VI FIBROBLASTS [J].
ANSON, DS ;
MULLER, V ;
BIELICKI, J ;
HARPER, GS ;
HOPWOOD, JJ .
BIOCHEMICAL JOURNAL, 1993, 294 :657-662
[2]   SIMULTANEOUS ABSENCE OF ALPHA-1,4-GLUCOSIDASE AND ALPHA-1,6-GLUCOSIDASE ACTIVITIES (PH 4) IN TISSUES OF CHILDREN WITH TYPE 2 GLYCOGEN STORAGE DISEASE [J].
BROWN, BI ;
BROWN, DH ;
JEFFREY, PL .
BIOCHEMISTRY, 1970, 9 (06) :1423-&
[3]   HUMAN ALPHA-L-IDURONIDASE .2. CATALYTIC PROPERTIES [J].
CLEMENTS, PR ;
MULLER, V ;
HOPWOOD, JJ .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1985, 152 (01) :29-34
[4]   PARTIAL ENZYME DEFICIENCIES - RESIDUAL ACTIVITIES AND THE DEVELOPMENT OF NEUROLOGICAL DISORDERS [J].
CONZELMANN, E ;
SANDHOFF, K .
DEVELOPMENTAL NEUROSCIENCE, 1984, 6 (01) :58-71
[5]   Enzyme replacement and enhancement therapies for lysosomal diseases [J].
Desnick, RJ .
JOURNAL OF INHERITED METABOLIC DISEASE, 2004, 27 (03) :385-410
[6]   ISOLATION AND CHARACTERIZATION OF A PRECURSOR FORM OF LYSOSOMAL ALPHA-GLUCOSIDASE FROM HUMAN-URINE [J].
ELFERINK, RPJO ;
BROUWERKELDER, EM ;
SURYA, I ;
STRIJLAND, A ;
KROOS, M ;
REUSER, AJJ ;
TAGER, JM .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1984, 139 (03) :489-495
[7]   Accelerated transport and maturation of lysosomal α-galactosidase A in Fabry lymphoblasts by an enzyme inhibitor [J].
Fan, JQ ;
Ishii, S ;
Asano, N ;
Suzuki, Y .
NATURE MEDICINE, 1999, 5 (01) :112-115
[8]   Brief report: Improvement in cardiac function in the cardiac variant of Fabry's disease with galactose-infusion therapy. [J].
Frustaci, A ;
Chimenti, C ;
Ricci, R ;
Natale, L ;
Russo, MA ;
Pieroni, M ;
Eng, CM ;
Desnick, RJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (01) :25-32
[9]  
FUJIMOTO A, 1978, CLIN CHIM ACTA, V90, P157
[10]   Isolation and characterisation of a recombinant, precursor form of lysosomal acid alpha-glucosidase [J].
Fuller, M ;
VanDerPloeg, A ;
Reuser, AJJ ;
Anson, DS ;
Hopwood, JJ .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1995, 234 (03) :903-909